Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

DMP-450: phase I/II results suggest promising antiviral efficacy, favorable toxicity profile

June 20, 2000

Data presented at Sitges workshop support further clinical development of DAPD

June 20, 2000

Cel-Sci begins another collaboration with the NCI

June 20, 2000

Interneuron licenses rights to PRO-2000

June 19, 2000

Gilead begins another multinational phase III trial of once-daily oral anti-HIV drug

June 19, 2000

New thiourea designed by Parker Hughes active against multidrug-resistant HIV-1

June 14, 2000

In vitro data support continued testing of AIDS vaccine in S. Africa

June 13, 2000

Enzo Biochem reports significant progress for HIV gene medicine

June 13, 2000

Abbott submits NDA for novel HIV therapy

June 6, 2000

Longer term Panretin therapy improves response rate

June 6, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...